Viewing Study NCT01191892


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2025-12-25 @ 3:06 PM
Study NCT ID: NCT01191892
Status: COMPLETED
Last Update Posted: 2019-05-16
First Post: 2010-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
Sponsor: Cardiff University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module